Novo mesto, 23 May – Slovenia’s pharma group Krka posted EUR 338.3m in sales in the first quarter of the year, an all-time quarterly high and a 5% increase on the same period last year. Net profit was up by 16% to EUR 49.4m. The rest of this news item is available to subscribers. Buy the news item. Price: 2 tokens; on account: 0 tokens.